Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoThe mRNA-1083 jab matched or bettered current flu jabs at making the body produce antibodies. The...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 6 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Combined flu and Covid vaccine 'triggers stronger immune response'
Daily Express· 3 days agoA combined jab for flu and Covid triggered a stronger immune response than separate single vaccines, according to data released by Moderna. The US pharmaceutical ...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 3 days agoOne of the most common reasons for bypassing the COVID vaccine is concern about side effects like tiredness, muscle and joint pain, chills, headache, fever ...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 3 days agoModerna said on Monday that its experimental combination vaccines against COVID-19 and the flu...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 3 days agoModerna’s RSV shot, dubbed Mresvia, was cleared by the FDA...for use in older adults. It’s the third...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 3 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoThe ongoing trial is testing the new vaccine in two groups of roughly 4,000 adults each: one group...